The global Gene Sequencing Services for Clinical Use market size is predicted to grow from US$ 4123 million in 2025 to US$ 12850 million in 2031; it is expected to grow at a CAGR of 20.9% from 2025 to 2031.

Gene sequencing services in clinical applications refer to the use of advanced sequencing technologies to diagnose, monitor and treat diseases at the genetic level. These services are often used in personalized medicine to tailor specific treatment plans for patients by analyzing their genetic information. Gene sequencing can be used to identify genetic diseases, evaluate cancer mutations, detect infectious pathogens or predict drug responses. Clinical gene sequencing plays a vital role in diagnosing rare and complex diseases, accurately understanding genetic mutations and providing more effective and personalized treatment plans. This service has been widely used in fields such as oncology, cardiology, neurology and genetic counseling.

United States market for Gene Sequencing Services for Clinical Use is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene Sequencing Services for Clinical Use is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene Sequencing Services for Clinical Use is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene Sequencing Services for Clinical Use players cover Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI, Natera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Gene Sequencing Services for Clinical Use Industry Forecast” looks at past sales and reviews total world Gene Sequencing Services for Clinical Use sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Sequencing Services for Clinical Use sales for 2025 through 2031. With Gene Sequencing Services for Clinical Use sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Sequencing Services for Clinical Use industry.

This Insight Report provides a comprehensive analysis of the global Gene Sequencing Services for Clinical Use landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Sequencing Services for Clinical Use portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Sequencing Services for Clinical Use market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Sequencing Services for Clinical Use and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Sequencing Services for Clinical Use.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Sequencing Services for Clinical Use market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Second-generation Sequencing
    Third- and Fourth-generation Sequencing
    First-generation Sequencing

Segmentation by Application:

    Third-party Laboratory
    Hospital
    Other

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Illumina
    Thermo Fisher Scientific
    Eurofins Scientific
    BGI
    Natera
    Berry Genomics
    Roche
    Novogene
    LabCorp
    Pacific Biosciences
    Azenta Life Sciences
    Oxford Nanopore
    Macrogen
    KingMed Testing
    Daan Gene
    Dian Diagnostics
    Adicon